Majer P

References (2)

Title : Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug - Rais_2022_Sci.Adv_8_eabq5925
Author(s) : Rais R , Lemberg KM , Tenora L , Arwood ML , Pal A , Alt J , Wu Y , Lam J , Aguilar JMH , Zhao L , Peters DE , Tallon C , Pandey R , Thomas AG , Dash RP , Seiwert T , Majer P , Leone RD , Powell JD , Slusher BS
Ref : Sci Adv , 8 :eabq5925 , 2022
Abstract : Rais_2022_Sci.Adv_8_eabq5925
ESTHER : Rais_2022_Sci.Adv_8_eabq5925
PubMedSearch : Rais_2022_Sci.Adv_8_eabq5925
PubMedID: 36383674

Title : Structure-activity relationship and biochemical evaluation of novel fibroblast activation protein and prolyl endopeptidase inhibitors with alpha-ketoamide warheads - Simkova_2021_Eur.J.Med.Chem_224_113717
Author(s) : Simkova A , Ormsby T , Sidej N , Slavetinska LP , Brynda J , Beranova J , Sacha P , Majer P , Konvalinka J
Ref : Eur Journal of Medicinal Chemistry , 224 :113717 , 2021
Abstract : Simkova_2021_Eur.J.Med.Chem_224_113717
ESTHER : Simkova_2021_Eur.J.Med.Chem_224_113717
PubMedSearch : Simkova_2021_Eur.J.Med.Chem_224_113717
PubMedID: 34371463